Legal & General Group PLC Arbutus Biopharma Corp Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Legal & General Group PLC holds 145,797 shares of ABUS stock, worth $504,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares
145,797
Previous 145,797 -0.0%
Holding current value
$504,457
Previous $561,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.12 - $4.56 $407,312 - $595,303
130,549 Added 856.17%
145,797 $561,000
Q2 2024

Aug 14, 2024
BUY
$2.52 - $3.63 $7,408 - $10,672
2,940 Added 23.89%
15,248 $47,000
Q3 2023

Nov 14, 2023
SELL
$1.9 - $2.27 $3,323 - $3,970
-1,749 Reduced 12.44%
12,308 $24,000
Q2 2023

Aug 14, 2023
BUY
$2.24 - $3.06 $4,164 - $5,688
1,859 Added 15.24%
14,057 $32,000
Q3 2022

Nov 14, 2022
BUY
$1.88 - $2.88 $3,256 - $4,988
1,732 Added 16.55%
12,198 $23,000
Q2 2022

Aug 22, 2022
BUY
$1.98 - $3.17 $4,979 - $7,972
2,515 Added 31.63%
10,466 $28,000
Q1 2022

May 16, 2022
BUY
$2.42 - $3.98 $3,450 - $5,675
1,426 Added 21.85%
7,951 $24,000
Q3 2021

Nov 15, 2021
BUY
$2.65 - $4.62 $752 - $1,312
284 Added 4.55%
6,525 $28,000
Q2 2021

Aug 12, 2021
BUY
$2.5 - $3.51 $15,602 - $21,905
6,241 New
6,241 $19,000
Q3 2019

Nov 13, 2019
SELL
$1.34 - $2.4 $7,030 - $12,592
-5,247 Closed
0 $0
Q1 2019

May 15, 2019
SELL
$3.41 - $4.57 $78,975 - $105,841
-23,160 Reduced 81.53%
5,247 $19,000
Q4 2018

Feb 15, 2019
BUY
$3.5 - $9.66 $13,534 - $37,355
3,867 Added 15.76%
28,407 $109,000
Q3 2018

Nov 20, 2018
BUY
$7.85 - $12.35 $151,450 - $238,268
19,293 Added 367.7%
24,540 $232,000
Q2 2018

Aug 10, 2018
BUY
$5.0 - $7.35 $26,235 - $38,565
5,247 New
5,247 $38,000

Others Institutions Holding ABUS

# of Institutions
156
Shares Held
99.6M
Call Options Held
2.31M
Put Options Held
525K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $519M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email